Metraipolis › archive › dc_d18c7d9eda35

Leveraging network pharmacology in the treatment of asthma — Europe PMC PMID:42633488

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42633488
DOI
10.5599/admet.3281
License (as archived)
solo-consultazione
Archived
2026-10-07T11:43:03.739Z
SHA-256 of the archived text
f3108f70941aa1dee4a39fd167246938fc230a5c46489486478f1a154f321e8e
Stable URL of this page
https://metraipolis.com/documento/dc_d18c7d9eda35

How to cite

Leveraging network pharmacology in the treatment of asthma — Europe PMC PMID:42633488 — Europe PMC (en), https://europepmc.org/article/MED/42633488 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d18c7d9eda35 (Metraipolis archive dc_d18c7d9eda35, sha256 f3108f70941aa1dee4a39fd167246938fc230a5c46489486478f1a154f321e8e)
BibTeX
@misc{dcd18c7d9eda35,
  title = {Leveraging network pharmacology in the treatment of asthma — Europe PMC PMID:42633488},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42633488},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d18c7d9eda35; sha256 f3108f70941aa1dee4a39fd167246938fc230a5c46489486478f1a154f321e8e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42633488. Agents can read the archived copy with the MCP tool read_document.